MaaT Pharma To Present and Participate in Investor and Medical Conferences in September Lyon, France,…
MaaT PharmaSeptember 4, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaJuly 5, 2024
MaaT Pharma: Half-year Report and an Increase of the Resources Allocated to the Liquidity Contract…
MaaT PharmaJuly 5, 2024
MaaT Pharma Announces First DSMB Positive Review of Ongoing Phase 2 Clinical Trial Evaluating MaaT033…
MaaT PharmaJuly 2, 2024
MaaT Pharma Announces Initiation of Coverage of its Stock by Stifel with a Buy Rating…
MaaT PharmaJune 25, 2024
MaaT Pharma Appoints Gianfranco Pittari, M.D. Ph.D, as Chief Medical Officer Lyon, France, June 24th…
MaaT PharmaJune 24, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaJune 10, 2024
MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting Lyon, France,…
MaaT PharmaMay 29, 2024
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION…
MaaT PharmaMay 15, 2024
